Gemini Model Reception
A new Gemini model has been released, but the AI world is not particularly impressed, raising questions about Alphabet's strategic positioning.
13Investing Insights
Analysis of Alphabet's Gemini model reception, the legal battle between Novo Nordisk and Eli Lilly, and GE Vernova's stock performance.
The episode discusses Alphabet's new Gemini model, which has received mixed reactions, alongside Novo Nordisk's lawsuit against Eli Lilly and GE Vernova's stock falling despite strong earnings.
1Listen to the source episode
Continue in GenPod
Key takeaways
A new Gemini model has been released, but the AI world is not particularly impressed, raising questions about Alphabet's strategic positioning.
13The discussion explores whether Alphabet is demonstrating superior business acumen or experiencing a loss of its competitive magic.
1Novo Nordisk has filed a lawsuit against Eli Lilly, a move interpreted as a sign of desperation within the pharmaceutical sector.
156GE Vernova's stock fell following a strong earnings report, prompting analysis of the energy sector's potential peak.
178Ask GenPod next
“What are the specific details of the lawsuit between Novo Nordisk and Eli Lilly?”
“How does the reception of the new Gemini model compare to previous AI releases?”
“What factors contributed to GE Vernova's stock falling despite strong earnings?”
Background reading
Market Context
The episode covers GE Vernova (GEV), Alphabet (GOOG), Novo Nordisk (NVO), and Eli Lilly (LLY).
9Questions
The AI world is not impressed with the new Gemini model.
1Novo Nordisk is suing Eli Lilly, a move described as stemming from desperation.
156Experts
Sources and disclosure
Ads are sponsored content. TMF does not endorse or verify ad statements. TMF is not involved in the offer or sale of advertised securities. Investors should conduct due diligence and consult advisors. TMF assumes no responsibility for losses. Opinions are the Fools' own. Products were loaned or purchased. Advertisers paid for sponsorship.
A new Gemini model is out and the AI world isn’t impressed. But is this Alphabet knowing its business better than anyone else or a loss of the company’s magic? Plus, we discuss Novo Nordisk suing Eli Lilly and GE Vernova’s stock falling after a great earnings report.
Travis Hoium, Lou Whiteman, and Jon Quast discuss:
- Gemini’s Model Dud?
- Gemini Pro Delay
- Novo Sues Eli Lilly
- Novo’s Desperation
- GE Vernova Earnings
- Energy’s Peak
Companies discussed: GE Vernova (GEV), Alphabet (GOOG), Novo Nordisk (NVO), Eli Lilly (LLY).
Host: Travis Hoium
Guests: Lou Whiteman, Jon Quast
Engineer: Dan Boyd
Disclosure: Advertisements are sponsored content and provided for informational purposes only.
The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements.
TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented.
Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions.
TMF assumes no responsibility for any losses or damages arising from this advertisement.
We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Related listening guides